http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1249539-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-811 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate | 1969-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1249539-A |
| titleOfInvention | Interferon induction |
| abstract | 1.249,539. Interferon - inducing medicines. TAKEDA YAKUHIN KOGYO K.K. 22 Dec., 1969 [24 Dec., 1968], No. 62263/69. Heading A5B. [Also in Division C3] A pharmaceutical composition comprises a double-stranded complex of a heteropolynucleotide consisting of inosinic and guanylic acid units and a homopolynucletide consisting essentially of cytidylic acid units (see Division C3) in a pharmaceutically acceptable carrier such as a phosphate-buffered saline solution. The composition may be administered parenterally or topically, and induces the formation of interferon and resistance to viral infection. |
| priorityDate | 1968-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.